longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HUAPONT LIFE SCIENCES released its 2024 annual performance, turning from profit to a loss of 299 million yuan

Zhitong
Apr 22, 2025 at 03:14 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, HUAPONT LIFE SCIENCES released its 2024 annual report. During the reporting period, the company achieved operating revenue of 11.665 billion yuan, a year-on-year increase of 0.60%. The net loss attributable to shareholders of the listed company was 299 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 338 million yuan. The basic loss per share was 0.1514 yuan

According to the Zhitong Finance APP, HUAPONT LIFE SCIENCES (002004.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 11.665 billion yuan, a year-on-year increase of 0.60%. The net loss attributable to shareholders of the listed company was 299 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 338 million yuan. The basic loss per share was 0.1514 yuan

Login to unlock490characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

HUAPONT HEALTH

HUAPONT HEALTH

002004.SZ

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI